Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A Prospective, Observational Study of HIV-Infected Pregnant Women and HIV-Exposed, Uninfected Children at Clinical Sites in Latin American Countries
OBSERVATIONAL
Inicio: 25 de jul de 2002
ID: NCT00341302
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab
INTERVENTIONAL
Inicio: 27 de nov de 2012
ID: NCT01705977
Completado
Fase 2
ClinicalTrials.gov
Ivermectin Reproposing for COVID-19 Treatment in Outpatients With Mild Stage
INTERVENTIONAL
Inicio: 20 de sept de 2020
ID: NCT04784481
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Nonalcoholic Steatohepatitis (NASH) and Fibrosis
INTERVENTIONAL
Inicio: 1 de mar de 2016
ID: NCT02704403
Completado
Fase 2
ClinicalTrials.gov
A Phase II Prospective, Open Label, Randomized, Active-controlled, Parallel Group, Multi-center 'Proof of Concept' Trial in Adult Patients With Complicated Skin or Skin Structure Infections Requiring Hospitalization.
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00303589
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Rilpivirine From Current INI-, NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-infected Adults Who Are Virologically Suppressed
INTERVENTIONAL
Inicio: 21 de abr de 2015
ID: NCT02422797
Desconocido
Fase 4
ClinicalTrials.gov
A Phase IIIB/IV Randomised Open-label Trial Comparing Dolutegravir With Pharmaco-enhanced Darunavir Versus Dolutegravir With Predetermined Nucleosides Versus Recommended Standard of Care ART Regimens in Patients With HIV-1 Infection Failing First Line Therapy.
INTERVENTIONAL
Inicio: 23 de nov de 2017
ID: NCT03017872
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, Versus Placebo Ointment Applied Twice Daily for 5 Days in the Treatment of Adult and Pediatric Subjects With SITL
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00684177
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Placebo-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adults With COVID-19 at High Risk for Disease Progression
INTERVENTIONAL
Inicio: 2 de dic de 2024
ID: NCT06667700
Reclutando
Fase 4
ClinicalTrials.gov
An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments
INTERVENTIONAL
Inicio: 27 de ago de 2024
ID: NCT06337032
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Multicenter Study Comparing MDX-010 Monotherapy, MDX-010 in Combination With a Melanoma Peptide Vaccine, and Melanoma Vaccine Monotherapy in HLA-A2*0201-Positive Patients With Previously Treated Unresectable Stage III or IV Melanoma
INTERVENTIONAL
Inicio: 1 de sept de 2004
ID: NCT00094653
Completado
ClinicalTrials.gov
HYPONATREMIA AND INFLAMMATION AND CLINICAL OUTCOMES IN HOSPITALIZED COVID-19 PATIENTS
OBSERVATIONAL
Inicio: 7 de mar de 2020
ID: NCT04493268
Completado
Fase 2
ClinicalTrials.gov
An Open Label Long Term Safety Extension Study of Apricitabine in Treatment-experienced HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00367952
Completado
Fase 3
ClinicalTrials.gov
COMPAS: A Phase III Study to Demonstrate Efficacy of GSK Biologicals' 10-valent Pneumococcal Vaccine (GSK1024850A) Against Community Acquired Pneumonia and Acute Otitis Media
INTERVENTIONAL
Inicio: 28 de jun de 2007
ID: NCT00466947
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Double-blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 Versus a Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections
INTERVENTIONAL
Inicio: 8 de mar de 2007
ID: NCT00413218
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Rilpivirine From Current INI-, NNRTI-, or PI-based Antiretroviral Regimen in HIV-1-Infected Adults Who Are Virologically Suppressed
INTERVENTIONAL
Inicio: 14 de abr de 2015
ID: NCT02429791
Completado
ClinicalTrials.gov
An International Observational Study to Characterize Adults Who Are Hospitalized With Influenza or Other Targeted Respiratory Viruses
OBSERVATIONAL
Inicio: 1 de ago de 2009
ID: NCT01056185
Terminado
ClinicalTrials.gov
Use of Corticosteroids in Children Hospitalized With Cellulitis: Randomized, Double Blind, Placebo Controlled Trial
INTERVENTIONAL
Inicio: 1 de jun de 2014
ID: NCT02087527
Terminado
ClinicalTrials.gov
A Multicenter, Observational, 6-Month Follow-up Study of Patients With COVID-19 Previously Enrolled in a RO7496998 (AT-527) Study
OBSERVATIONAL
Inicio: 15 de jun de 2021
ID: NCT05059080
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Phase III Study of Regorafenib Plus BSC Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01103323
Anterior
1
...
29
30
31
...
434
Siguiente
Filtros